BV-FAPESP: research projects supported in this Center
HUG-CELL in the Media: news about the Center
The Human Genome and Stem Cell Research Center (HUG-CELL) of the Institute of Biosciences of the University of São Paulo is a two-way effort: patients contribute to research and new scientific advances contribute to patients’ diagnosis and prevention of genetic disorders.
The Human Genome and Stem Cell Research Center (HUG-CELL) conducts research in human and medical genetics, providing genetic counseling services and genetic tests for the population, as well as developing activities related to genetics education and technology transfer. In addition, HUG-CELL develops research on emerging topics that are relevant for society, such as the genetic susceptibility responsible for microcephaly in babies exposed to the zika virus and the current search for germline genetic variants associated with the clinical variability of COVID-19.
The Human Genome and Stem Cell Research Center (HUG-CELL) team at USP is composed of genetics professors and researchers, physicians, health professionals, specialized technicians as well as graduate and post-graduate students, totaling around 120 participants.
The Human Genome and Stem Cell Research Center (HUG-CELL) is the largest center for attending people with genetic diseases in Latin America. It represents the continuity of Prof. Oswaldo Frota-Pessoa initiative, a pioneer of genetic medicine in Brazil, who started to ascertain and offer genetic counseling to families with genetic diseases in the 1960s. Since then, with the inauguration of the HUG-CELL building in 2000, around 100 thousand people from families affected by different genetic pathologies have been attended by a multidisciplinary team.
2020-11-18
Analysis of DNA from 1,171 over-sixties living in São Paulo will enable scientists to identify genetic mutations responsible for diseases or important to healthy aging, according to the authors of the study.
2020-10-28
Findings reported by Brazilian researchers in PLOS Neglected Tropical Diseases help explain why only some babies whose mothers are infected during pregnancy are born with microcephaly and other anomalies.
2020-08-26
A study is being conducted by a research center supported by FAPESP to determine whether people who develop severe forms of the disease have risk genes and whether asymptomatic people or patients with only mild symptoms have protective genes.
2019-12-18
Technique developed at Human Genome and Stem Cell Research Center, funded by FAPESP and hosted by the University of São Paulo, produced hepatic tissue in the laboratory in only 90 days and could become an alternative to organ transplantation in future.